338 related articles for article (PubMed ID: 34590446)
1. Formation and Cellular Impact of Cholesterol Crystals in Health and Disease.
Baumer Y; McCurdy SG; Boisvert WA
Adv Biol (Weinh); 2021 Nov; 5(11):e2100638. PubMed ID: 34590446
[TBL] [Abstract][Full Text] [Related]
2. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability.
Nidorf SM; Fiolet A; Abela GS
J Clin Lipidol; 2020; 14(5):619-630. PubMed ID: 32792218
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
Niyonzima N; Bakke SS; Gregersen I; Holm S; Sandanger Ø; Orrem HL; Sporsheim B; Ryan L; Kong XY; Dahl TB; Skjelland M; Sørensen KK; Rokstad AM; Yndestad A; Latz E; Gullestad L; Andersen GØ; Damås JK; Aukrust P; Mollnes TE; Halvorsen B; Espevik T
EBioMedicine; 2020 Oct; 60():102985. PubMed ID: 32927275
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol-embolization syndrome: current perspectives.
Ozkok A
Vasc Health Risk Manag; 2019; 15():209-220. PubMed ID: 31371977
[TBL] [Abstract][Full Text] [Related]
5. Activation of NLRP3 inflammasome by cholesterol crystals in alcohol consumption induces atherosclerotic lesions.
Abdul-Muneer PM; Alikunju S; Mishra V; Schuetz H; Szlachetka AM; Burnham EL; Haorah J
Brain Behav Immun; 2017 May; 62():291-305. PubMed ID: 28232172
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acid.
John Chapman M; Preston Mason R
Pharmacol Ther; 2022 Dec; 240():108237. PubMed ID: 35772589
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation.
Bakke SS; Aune MH; Niyonzima N; Pilely K; Ryan L; Skjelland M; Garred P; Aukrust P; Halvorsen B; Latz E; Damås JK; Mollnes TE; Espevik T
J Immunol; 2017 Oct; 199(8):2910-2920. PubMed ID: 28855312
[TBL] [Abstract][Full Text] [Related]
8. Killing the Culprit: Pharmacological Solutions to Get Rid of Cholesterol Crystals.
Iranshahy M; Banach M; Hasanpour M; Lavie CJ; Sahebkar A
Curr Probl Cardiol; 2022 Sep; 47(9):101274. PubMed ID: 35661813
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.
Samstad EO; Niyonzima N; Nymo S; Aune MH; Ryan L; Bakke SS; Lappegård KT; Brekke OL; Lambris JD; Damås JK; Latz E; Mollnes TE; Espevik T
J Immunol; 2014 Mar; 192(6):2837-45. PubMed ID: 24554772
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol crystals at the culprit lesion in patients with acute coronary syndrome are associated with worse cardiovascular outcomes at two years follow up - results from the translational OPTICO-ACS study program.
Nelles G; Abdelwahed YS; Seppelt C; Meteva D; Stähli BE; Rai H; Seegers LM; Sieronski L; Musfeldt J; Gerhardt T; Riedel M; Skurk C; Haghikia A; Sinning D; Dreger H; Knebel F; Trippel TD; Krisper M; Klotsche J; Joner M; Landmesser U; Leistner DM
Int J Cardiol; 2024 Mar; 399():131665. PubMed ID: 38141724
[TBL] [Abstract][Full Text] [Related]
12. The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis.
Abideen ZU; Pathak DR; Sabanci R; Manu M; Abela GS
Front Cardiovasc Med; 2024; 11():1345521. PubMed ID: 38495937
[TBL] [Abstract][Full Text] [Related]
13. Frequency of Cholesterol Crystals in Culprit Coronary Artery Aspirate During Acute Myocardial Infarction and Their Relation to Inflammation and Myocardial Injury.
Abela GS; Kalavakunta JK; Janoudi A; Leffler D; Dhar G; Salehi N; Cohn J; Shah I; Karve M; Kotaru VPK; Gupta V; David S; Narisetty KK; Rich M; Vanderberg A; Pathak DR; Shamoun FE
Am J Cardiol; 2017 Nov; 120(10):1699-1707. PubMed ID: 28867129
[TBL] [Abstract][Full Text] [Related]
14. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects.
Goeller M; Achenbach S; Marwan M; Doris MK; Cadet S; Commandeur F; Chen X; Slomka PJ; Gransar H; Cao JJ; Wong ND; Albrecht MH; Rozanski A; Tamarappoo BK; Berman DS; Dey D
J Cardiovasc Comput Tomogr; 2018; 12(1):67-73. PubMed ID: 29233634
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
Qin Z; Cao M; Xi X; Zhang Y; Wang Z; Zhao S; Tian Y; Xu Q; Yu H; Tian J; Yu B
Int J Cardiol; 2022 Oct; 364():162-168. PubMed ID: 35705168
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol Crystals as the Main Trigger of Interleukin-6 Production through Innate Inflammatory Response in Human Spontaneously Ruptured Aortic Plaques.
Komatsu S; Yutani C; Takahashi S; Takewa M; Iwa N; Ohara T; Kodama K
J Atheroscler Thromb; 2023 Nov; 30(11):1715-1726. PubMed ID: 37081615
[TBL] [Abstract][Full Text] [Related]
17. The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study.
Xue C; Chen Q; Bian L; Yin Z; Xu Z; Zhang H; Zhang Q; Zhang J; Wang C; Du R; Fan L
Front Cardiovasc Med; 2022; 9():905363. PubMed ID: 36386333
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cholesterol crystals in carotid plaque by dual energy computed tomography.
Saito T; Endo H; Ando D; Miyagi I; Kawabata Y; Watanabe M; Saito A; Fujimura M; Yazawa Y
Neuroradiology; 2023 May; 65(5):979-982. PubMed ID: 36869934
[TBL] [Abstract][Full Text] [Related]
19. Debris collected in-situ from spontaneously ruptured atherosclerotic plaque invariably contains large cholesterol crystals and evidence of activation of innate inflammation: Insights from non-obstructive general angioscopy.
Komatsu S; Yutani C; Takahashi S; Takewa M; Ohara T; Hirayama A; Kodama K
Atherosclerosis; 2022 Jul; 352():96-102. PubMed ID: 35300852
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
